Saturday 17 October 2026
Export RDNT’s income statement to Excel — free account
RadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 25.0%, EPS fell 47.4%, free cash flow fell 43.2% and total debt rose 21.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
68.53
1.88
−2.67%
Follow RDNT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (1.64%) | (1.14%) | (1.50%) | (1.04%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
3 | 5 | 3 | 3 | |
| (0.55%) | (0.39%) | (0.53%) | (0.37%) | ||
ROIC |
2.24% | 1.98% | 2.31% | 2.32% | |
Return on Tangible Assets |
(1.73%) | (1.47%) | (1.49%) | (0.99%) | |
Average Days of Receivables |
38.91 | 35.59 | 35.84 | 39.02 | |
Free Cash Flow per Share |
0.96 | 1.34 | 1.16 | 0.69 | |
Free Cash Flow |
74.36 | 103.50 | 86.86 | 52.14 | |
Capital Expenditures |
(235.70) | (232.81) | (211.96) | (205.05) | |
| Other line items | |||||
Cash ROIC |
2.17% | 3.60% | 2.70% | 1.63% | |
Accounts Receivable Turnover |
10.27 | 10.48 | 10.57 | 9.62 | |
Accounts Payable Turnover |
4.48 | 4.62 | 4.67 | 4.60 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
89.07 | 87.25 | 85.35 | 87.72 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.45) | (0.32) | (0.47) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
2.61% | 2.68% | 2.68% | 2.78% | |
Interest Coverage |
0.99 | 0.88 | 0.89 | 0.84 | |
Operating CF/Net income |
(14.68) | (23.70) | (16.02) | (20.23) | |
Depreciation/Fixed assets |
0.27 | 0.26 | 0.27 | 0.27 | |
Capex/Depreciation |
(0.99) | (1.02) | (0.98) | (0.96) | |
Revenue per Share |
29.17 | 27.83 | 27.13 | 25.93 | |
Operating CF per Share |
3.99 | 4.36 | 3.97 | 3.39 | |
Capex per Share |
(3.03) | (3.02) | (2.82) | (2.70) | |
Capex to Sales |
0.10 | 0.11 | 0.10 | 0.10 |
Columns are period end dates